ribavirin has been researched along with galactose in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fiume, L; Verme, G | 1 |
| Cavallaro, G; Craparo, EF; Giammona, G; Pitarresi, G; Triolo, D | 1 |
| BondÃ, ML; Cavallaro, G; Craparo, EF; Licciardi, M; Teresi, G | 1 |
| Chen, JX; Hu, RF; Li, HY; Li, Y; Wu, L; Yin, XZ; Zhang, JW | 1 |
| Abd-Rabou, AA; Bharali, DJ; Mousa, SA | 1 |
| Abdallah, Y; El-Ridy, M; Hashim, F; Nasr, M | 1 |
1 review(s) available for ribavirin and galactose
| Article | Year |
|---|---|
Liver targeting of nucleoside analogues coupled to galactosyl terminating macromolecules: a new approach to the treatment of a chronic viral hepatitis.
Topics: Amino Sugars; Animals; Antiviral Agents; Asialoglycoproteins; DNA; Drug Carriers; Galactose; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Liver; Lysosomes; Polylysine; Ribavirin; Serum Albumin; Vidarabine Phosphate; Virus Replication | 1997 |
5 other study(ies) available for ribavirin and galactose
| Article | Year |
|---|---|
Galactosylated micelles for a ribavirin prodrug targeting to hepatocytes.
Topics: Antiviral Agents; Galactose; Hep G2 Cells; Humans; Liver; Magnetic Resonance Spectroscopy; Micelles; Prodrugs; Ribavirin; Spectroscopy, Fourier Transform Infrared | 2013 |
Novel composed galactosylated nanodevices containing a ribavirin prodrug as hepatic cell-targeted carriers for HCV treatment.
Topics: Antiviral Agents; Diffusion; Galactose; Hep G2 Cells; Hepatitis C; Humans; Materials Testing; Nanocapsules; Prodrugs; Ribavirin | 2013 |
[Applicability of a natural swelling matrix as the propellant of osmotic pump tablets].
Topics: Arabinose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Galactose; Glipizide; Malvaceae; Osmosis; Plants, Medicinal; Rhamnose; Ribavirin; Seeds; Solubility; Tablets; Technology, Pharmaceutical; Viscosity; Water; Xylose | 2013 |
Viramidine-Loaded Galactosylated Nanoparticles Induce Hepatic Cancer Cell Apoptosis and Inhibit Angiogenesis.
Topics: Angiogenesis Inhibitors; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Galactose; Hep G2 Cells; Humans; Liver Neoplasms; MCF-7 Cells; Nanoparticles; Neovascularization, Pathologic; Ribavirin | 2020 |
Preparation and characterization of niosomes containing ribavirin for liver targeting.
Topics: Animals; Antiviral Agents; Cholesterol; Drug Delivery Systems; Drug Stability; Excipients; Female; Hexoses; Injections, Intraperitoneal; Liposomes; Liver; Organophosphates; Particle Size; Rats; Refrigeration; Ribavirin | 2010 |